Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.

Abstract

BACKGROUND:

Pancreatitis is one of the major complications of ERCP and endoscopic sphincterotomy. It has been shown that nonsteriodal anti-inflammatory drugs are potent inhibitors of phospholipase A(2), activity which is increased in pancreatitis. A previous study showed reduction of post-ERCP pancreatitis with administration of rectal diclofenac.

OBJECTIVE:

The aim of this study was to determine whether prophylactic oral diclofenac will reduce the incidence and the severity of ERCP-induced pancreatitis, especially in high-risk patients.

DESIGN:

Single-center, randomized, double-blinded, prospective study.

SETTING:

Indiana University Medical Center.

PATIENTS:

A total of 207 evaluable patients were randomized to receive either diclofenac 50 mg or placebo by mouth 30 to 90 minutes before and 4 to 6 hours after ERCP.

RESULTS:

The groups were similar with regard to patient demographics and to patient and procedure risk factors for post-ERCP pancreatitis. The overall incidence of post-ERCP pancreatitis was 16.4%. It occurred in 17 of 102 patients in the control group (16.7%) and in 17 of 105 patients in diclofenac group (16.2%). The pancreatitis was graded mild in 9.8%, moderate in 5.9%, and severe 1.0% of the control group, and mild in 10.5%, moderate in 4.8%, and severe in 1.0% of the diclofenac group. In high-risk patients, the incidence of post-ERCP pancreatitis was 17.3%. It occurred in 18.0% (16/89) in the control group and in 17.8% (16/90) in the diclofenac group. There was no significant difference between the groups in the frequency or severity of post-ERCP pancreatitis in overall and high-risk patients; however, the power of the study was less than 45%.

CONCLUSIONS:

Prophylactic orally administered diclofenac was not observed to affect the frequency or severity of post-ERCP pancreatitis in high-risk patients.

• Authors: Young Koog Cheon, Kwang Bum Cho, James L Watkins, Lee McHenry, Evan L Fogel, Stuart Sherman, Suzette Schmidt, Laura Lazzell-Pannell, Glen A Lehman
• Journal: Gastrointestinal endoscopy (Gastrointest Endosc) Vol. 66 Issue 6 Pg. 1126-32 (Dec 2007) ISSN: 0016-5107 [Print] United States
• PMID: 18061712 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Diclofenac

Topics

• Administration, Oral
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
• Diclofenac (administration & dosage)
• Double-Blind Method
• Female
• Humans
• Male
• Middle Aged
• Pancreatic Diseases (diagnosis)
• Pancreatitis (epidemiology, etiology, prevention & control)
• Primary Prevention (methods)
• Prospective Studies